Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 30
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text

ALEMBIC

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 30
  • 0 comments

FDA approve ALBENDAZOLE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 28
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text

UNICHEM

  • FDA Approval
  • Sept. 06, 2024, 04:15 UTC
  • 32
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 28
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 31
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 25
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

HENGRUI PHARMA

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 26
  • 0 comments

FDA approve CASPOFUNGIN ACETATE

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 30
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

PROVEPHARM SAS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 17
  • 0 comments

FDA approve DIHYDROERGOTAMINE MESYLATE

Comment Full text
  • Previous
  • 268
  • 269
  • 270
  • 271
  • 272
  • Next

Search

News categories

  • Technical Exchange News(9977)
  • Event(412)
  • SEC News(168776)
  • FDA Approval(9377)
  • Company Report(721)
  • Business News(112464)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin